Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019

Published:2020-04-24 Issue:4 Volume:3 Page:e209035
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Fihn Stephan D.¹²³,Perencevich Eli⁴⁵⁶,Bradley Steven M.⁶⁷

Affiliation:

1. Department of Medicine, Harborview Medical Center, University of Washington, Seattle

2. Department of Health Services, Harborview Medical Center, University of Washington, Seattle

3. Deputy Editor, JAMA Network Open

4. Center for Access an Delivery Research and Evaluation, Iowa City VA Health Care System, Iowa City, Iowa

5. Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City

6. Associate Editor, JAMA Network Open

7. Healthcare Delivery Innovation Center, Minneapolis Heart Institute, Minneapolis, Minnesota

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2765500/fihn_2020_ed_200005.pdf

Reference7 articles.

1. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial.;Borba;JAMA Netw Open,2020

2. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.;Gao;Biosci Trends,2020

3. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.;Gautret;Int J Antimicrob Agents,2020

4. The DataLab. Covid-19 trials tracker. Accessed April 21, 2020. http://covid19.trialstracker.net/

5. International Society of Antimicrobial Chemotherapy. Statement on IJAA paper. Accessed April 21, 2020. https://www.isac.world/news-and-publications/official-isac-statement

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laser liquid ablation for silver nanoparticles synthesis and conjugation with hydroxychloroquine for Covid-19 treatment;Materials Today: Proceedings;2023-08

2. Long COVID in autoimmune rheumatic diseases;Rheumatology International;2023-03-30

3. A scoping review of digital health interventions for combating COVID-19 misinformation and disinformation;Journal of the American Medical Informatics Association;2023-01-27

4. Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis;PLOS ONE;2022-09-29

5. Safety profile of hydroxychloroquine used off‐label for the treatment of patients with COVID‐19: A descriptive study based on EudraVigilance data;Fundamental & Clinical Pharmacology;2022-05-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3